Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Depakote ER for Migraine Prophylaxis in Adolescents
NCT00195806Phase 3Completed
- Sponsor
- Abbott Laboratories
- Start
- Feb 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of divalproex sodium in migraine, sponsored by Abbott Laboratories. Primary endpoint: Number of migraine headache days at 1 year. Started Feb 2005; status: completed.
02
Drugs
divalproex sodium
03
Conditions
migraine
Beyond the preview
Go deeper on NCT00195806.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00195806.